Breaking: Bayer buys Monsanto: the Empire strikes back
By Jon Rappoport
This is the largest corporate cash buyout in history.
Mega-giant Bayer put $66 billion on the table, and mega-giant Monsanto said yes.
Think GMOs, crop seeds, pesticides, medical drugs.
Keep in mind that one of the consultants on the European side of this deal is the Rothschild Group.
But that’s not all. Dow and DuPont are planning to merge. Recently, another biotech giant, Syngenta, was swallowed up by the state-owned ChemChina. And this just in: two major Canadian fertilizer manufacturers, Potash Corp of Saskatchewan Inc. and Agrium Inc. are merging.
Consolidation, monopoly. The Empire strikes back.
The global rebellion against GMOs and pesticides, particularly Monsanto’s Roundup, is one of the reasons for these deals. But lurking in the background is another factor, exemplified by the pending Trans-Pacific Partnership (TPP) treaty.
If the TPP passes, corporate tribunals will take over the adjudication of disputes in which a nation rejects importing toxic pesticides, medical drugs, or GMOs. These tribunals will decide whether that nation is permitted to refuse importation.
Of course, the tribunals will favor mega-corporate interests. But now, with the mergers involving Bayer, Monsanto, Dow, DuPont, Syngenta, and ChemChina, the devastating clout of the tribunals will be that much more powerful.
The ability to shove toxic products down the throats of populations will elevate.
This is the corporate face of Globalism.
This is a giant step in the direction of controlling the world’s food supply.
You can draw another arrow connecting these corporations to Bill Gates, whose foundation avidly supports their efforts.
If Gates and George Soros still own the Monsanto stock they bought in 2010— 900,000 and 500,000 shares, respectively—they just received a nice chunk of pocket change from the Bayer buyout. As part of the deal, every Monsanto share will suddenly be worth $22 more than yesterday’s price.